Literature DB >> 22684561

Inhibitory effects of microRNA-34a on cell migration and invasion of invasive urothelial bladder carcinoma by targeting Notch1.

Chao Zhang1,2, Zhiyong Yao3, Mingyang Zhu1, Xin Ma1, Taoping Shi1, Hongzhao Li1, Baojun Wang1, Jinzhi Ouyang4, Xu Zhang5.   

Abstract

MicroRNAs (miRNAs or miRs) are a class of short, non-coding RNAs that participate in various oncological processes. This study aims to explore the roles of microRNA-34a (miR-34a) in invasive urothelial bladder carcinoma. miR-34a was transfected into bladder cancer cell lines 253J and J82. The miR-34a expression levels in tissues and cells were detected by using qRT-PCR. The Notch1 expression was detected by qRT-PCR and Western blotting. Cell migratory and invasive abilities were measured by Transwell chamber assay. Bioinformatics and luciferase assay were performed to predict and analyze the binding sites between miRNA-34a and Notch1. It was found that there was aberrant expression of miR-34a in bladder cancer tissues. Moreover, we revealed that ectopic expression of miR-34a suppressed cell migration and invasion, while forced expression of Notch1 increased cell migratory and invasive abilities. Finally, we observed that miR-34a transfection significantly down-regulated luciferase activity and reduced the mRNA and protein levels of Notch1. Our study concluded that microRNA-34a antagonizes Notch1 and inhibits cell migration and invasion of bladder cancer cells, which indicates the tumor-suppressive function of microRNA-34a in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684561     DOI: 10.1007/s11596-012-0065-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  35 in total

Review 1.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

2.  MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.

Authors:  Ruth L Vinall; Alexandra Z Ripoll; Sisi Wang; Chong-Xian Pan; Ralph W deVere White
Journal:  Int J Cancer       Date:  2011-12-02       Impact factor: 7.396

3.  Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.

Authors:  Srinivasulu Chigurupati; Rajarajeswari Venkataraman; Daniel Barrera; Anusha Naganathan; Meenu Madan; Leena Paul; Jogi V Pattisapu; George A Kyriazis; Kiminobu Sugaya; Sergey Bushnev; Justin D Lathia; Jeremy N Rich; Sic L Chan
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

4.  Notch1 is involved in migration and invasion of human breast cancer cells.

Authors:  Jing Wang; Li Fu; Feng Gu; Yongjie Ma
Journal:  Oncol Rep       Date:  2011-07-22       Impact factor: 3.906

Review 5.  Beta-catenin: a key mediator of Wnt signaling.

Authors:  K Willert; R Nusse
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

6.  A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer.

Authors:  Bastiaan T Heijmans; Jolanda M A Boer; H Eka D Suchiman; Cees J Cornelisse; Rudi G J Westendorp; Daan Kromhout; Edith J M Feskens; P Eline Slagboom
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro.

Authors:  Irina A Potapova; Glenn R Gaudette; Peter R Brink; Richard B Robinson; Michael R Rosen; Ira S Cohen; Sergey V Doronin
Journal:  Stem Cells       Date:  2007-03-29       Impact factor: 6.277

8.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

Authors:  M Crawford; E Brawner; K Batte; L Yu; M G Hunter; G A Otterson; G Nuovo; C B Marsh; S P Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

9.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

10.  Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.

Authors:  H Matsumoto; H Matsuyama; K Fukunaga; S Yoshihiro; T Wada; K Naito
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more
  17 in total

1.  MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression.

Authors:  Zhen-Shan Ding; Yu-Hui He; Yi-Sen Deng; Pan-Xin Peng; Jian-Feng Wang; Xing Chen; Pei-Yu Zhao; Xiao-Feng Zhou
Journal:  Oncol Lett       Date:  2019-09-18       Impact factor: 2.967

2.  MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion.

Authors:  Yi Wan; Guan Sun; Shuguang Zhang; Zhimin Wang; Lei Shi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-07-09       Impact factor: 2.416

Review 3.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

4.  MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.

Authors:  Yu-Mei Rao; Hui-Rong Shi; Mei Ji; Cai-Hong Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

5.  MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.

Authors:  Xin Xu; Hong Chen; Yiwei Lin; Zhenghui Hu; Yeqing Mao; Jian Wu; Xianglai Xu; Yi Zhu; Shiqi Li; Xiangyi Zheng; Liping Xie
Journal:  Mol Cells       Date:  2013-05-30       Impact factor: 5.034

6.  Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.

Authors:  Angeline S Andrew; Carmen J Marsit; Alan R Schned; John D Seigne; Karl T Kelsey; Jason H Moore; Laurent Perreard; Margaret R Karagas; Lorenzo F Sempere
Journal:  Int J Cancer       Date:  2015-02-25       Impact factor: 7.396

Review 7.  Notch signal integration in the vasculature during remodeling.

Authors:  Bahman Rostama; Sarah M Peterson; Calvin P H Vary; Lucy Liaw
Journal:  Vascul Pharmacol       Date:  2014-11       Impact factor: 5.773

8.  Inhibition of Notch signaling facilitates the differentiation of human-induced pluripotent stem cells into neural stem cells.

Authors:  Chun-Yuan Chen; Wei Liao; Yuan-Lei Lou; Qing Li; Bin Hu; Yang Wang; Zhi-Feng Deng
Journal:  Mol Cell Biochem       Date:  2014-06-28       Impact factor: 3.396

9.  Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.

Authors:  Qing Bo Huang; Xin Ma; Xu Zhang; Shang Wen Liu; Qing Ai; Tao Ping Shi; Yu Zhang; Yu Gao; Yang Fan; Dong Ni; Bao Jun Wang; Hong Zhao Li; Tao Zheng
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

10.  miR-34a inhibits proliferation and invasion of bladder cancer cells by targeting orphan nuclear receptor HNF4G.

Authors:  Huaibin Sun; Jun Tian; Wanhua Xian; Tingting Xie; Xiangdong Yang
Journal:  Dis Markers       Date:  2015-03-23       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.